Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03518138
What this trial is testing

Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor

Who this might be right for
Vasomotor Symptoms (VMS)
Que Oncology 132
Not applicableStudy completedNCT01384526
What this trial is testing

Investigating the Impact of Tamoxifen Therapy on Ovarian Aging

Who this might be right for
Breast CancerFertility
University of California, San Francisco 266
Large-scale testing (Phase 3)Study completedNCT00309478
What this trial is testing

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Who this might be right for
Early-stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 1,099
Large-scale testing (Phase 3)UnknownNCT00382070
What this trial is testing

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,966
Testing effectiveness (Phase 2)UnknownNCT02313051
What this trial is testing

Everolimus trIal for Advanced prememopausaL Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Ended earlyNCT00096369
What this trial is testing

Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 130
Not applicableUnknownNCT02488603
What this trial is testing

Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

Who this might be right for
Breast Cancer
National Cancer Center, Korea 360
Large-scale testing (Phase 3)UnknownNCT00010140
What this trial is testing

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
International Collaborative Cancer Group
Large-scale testing (Phase 3)Study completedNCT00107263
What this trial is testing

Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Alliance for Clinical Trials in Oncology 558
Not applicableStudy completedNCT01511575
What this trial is testing

Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder

Who this might be right for
Leukemia
Children's Oncology Group 60
Testing effectiveness (Phase 2)UnknownNCT00077168
What this trial is testing

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 2,000
Not applicableStudy completedNCT00014235
What this trial is testing

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more
Fred Hutchinson Cancer Center 160
Testing effectiveness (Phase 2)Looking for participantsNCT06361940
What this trial is testing

Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 100
Not applicableStudy completedNCT00667121
What this trial is testing

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Who this might be right for
Breast CancerDepressionHot Flashes+1 more
Mayo Clinic 88
Not applicableStudy completedNCT01169792
What this trial is testing

Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients

Who this might be right for
Breast NeoplasmsSurvival AnalysisAntineoplastic Agents+1 more
Yonsei University
Large-scale testing (Phase 3)Study completedNCT00279448
What this trial is testing

Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 9,779
Early research (Phase 1)Study completedNCT00001504
What this trial is testing

A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients

Who this might be right for
Breast CancerBreast Neoplasm
National Cancer Institute (NCI) 18
Very early researchWithdrawnNCT00993642
What this trial is testing

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Who this might be right for
Breast Cancer
Tulane University Health Sciences Center
Post-approval studies (Phase 4)Study completedNCT01553903
What this trial is testing

Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not

Who this might be right for
Breast Cancer
Institut Claudius Regaud 29
Very early researchLooking for participantsNCT04174352
What this trial is testing

FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

Who this might be right for
ERα+ Breast CancerESR1 Gene Mutation
University of Wisconsin, Madison 12
Next Page